Mandatory notification of trade
(Thomson Reuters ONE) -
22 June 2011, Lysaker, Norway: Company owned by primary insider and member of
the board of directors' of Pronova BioPharma ASA, Hilde Furberg, has bought
20,000 shares in Pronova BioPharma ASA.
The shares were bought at an average share price of NOK 10.28 and are held by
J&J Future Invest AS, which is owned 50% by Ms Furberg. The total number of
shares held by J&J Future Invest AS, after the purchase, is 20,000
This information is subject of the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Pronova BioPharma ASA via Thomson Reuters ONE
[HUG#1525013]
Unternehmensinformation / Kurzprofil:
Datum: 22.06.2011 - 07:00 Uhr
Sprache: Deutsch
News-ID 55744
Anzahl Zeichen: 1172
contact information:
Town:
Lysaker
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 129 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Mandatory notification of trade"
steht unter der journalistisch-redaktionellen Verantwortung von
Pronova BioPharma ASA (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
